- Lobbying
- pathway AND strategies
Lobbying Arrangements Results for 'Pathway Strategies'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details healthcare reform |
Pathway Genomics Corporation
|
Legislative Strategies CA | |||
Details FY2011 Defense Appropriations Bill |
Digital ArtForms, Inc(AKA Pathway Strategies, LLC on behalf of Digital Artforms)
Government Consulting/Lobbying |
JK Wilson, LLC | |||
Details FY09 Defense Appropriations FY09 TTHUD Appropriations FY09 Energy and Water Appropriations |
Pathway Strategies, LLC
|
JK Wilson, LLC | |||
Details Defense Appropriations Bills |
Radiance Technologies, Inc.
Defense Contracting |
PATHWAY STRATEGIES, LLC | |||
Details Land Trust for local Japanese American communities in California |
California Japanese American Leadership Council
|
PATHWAY STRATEGIES, LLC | |||
Details FY09 Natural Resources Act |
Pathway Strategies, LLC on behalf of The City of King Cove, Alaska
|
JK Wilson, LLC | |||
Details HR 2801 Izembek Enhancement Act S 1630 Izembek Enhancement Act |
City of King Cove, Alaska
|
PATHWAY STRATEGIES, LLC | |||
Details FY09 Energy and Water Appropriations FY09 TTHUD Appropriations |
Pathway Strategies, LLC on behalf of the City of Whittier, Alaska
|
JK Wilson, LLC | |||
Details Defense Appropriations Bill |
National Japanese American Historical Society
Ethnic History and Cultural Preservation |
PATHWAY STRATEGIES, LLC | |||
Details Military Intelligence Service Historical Learning Center |
National Japanese American Historical Society
|
PATHWAY STRATEGIES, LLC | |||
Details community youth center |
JAPANESE COMMUNITY YOUTH COUNCIL
|
PATHWAY STRATEGIES, LLC | |||
Details funding for iMEDIC, a virtual medical consultation system |
DIGITAL ARTFORMS
|
PATHWAY STRATEGIES, LLC | |||
Details Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway |
AMAG Pharmaceuticals
|
ZIRKELBACH STRATEGIES | |||
Details Issues related to medical device technology and FDA accelerated pathway |
EMulate Therapeutics
|
STRATEGIES 360 | |||
Details Hwy Funding Flood Control planning |
COUNTY OF KAUAI, HAWAII
|
PATHWAY STRATEGIES, LLC | |||
Details -Advocate for biopharmaceutical cost-containment policies aimed at creating an abbreviated pathway for access to generic biologic medications |
Momenta Pharmaceuticals, Inc.
Biopharmaceuticals |
Jennings Policy Strategies, Inc. | |||
Details -Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promote competition in the pharmaceutical marketplace. |
Coalition for a Competitive Pharmaceutical Marketplace
Health care coalition |
JENNINGS POLICY STRATEGIES, INC. | |||
Details -Advocate for biopharmaceutical cost-containment policies aimed at creating an abbreviated pathway for access to generic biologic medications |
California Employees Public Retirees System
Administers retirement and health benefits for California public employees |
Jennings Policy Strategies | |||
Details General issues related to EPA electric pathway |
Bridge to Renewables
|
ML STRATEGIES, LLC | |||
Details Pharmaceutical issues related to womens health product access and education on the accelerated approval pathway. |
AMAG Pharmaceutical
|
Sims Strategies, LLC | |||
Details Government relations objectives related to Congress and the Administration, including: abbreviated biogeneric approval pathway, oversight of medical device manufacturers, drug safety tracking measu... |
Hospira, Inc.
|
VENN STRATEGIES, LLC | |||
Details Shotgun Cove Road funding Navigation Improvements Whittier Harbor |
CITY OF WHITTIER, ALASKA
|
PATHWAY STRATEGIES, LLC | |||
Details FY07 Energy & Water Appropriations (flood management) FY07 TTHUD Appropriations (transportation, economic development) FY06 Emergency Supplemental (disaster relief) |
County of Kauai
local government |
Pathway Strategies, LLC | |||
Details Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Educate... |
Genentech, Inc.
|
W Strategies, LLC | |||
Details Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace,... |
Coalition for a Competitive Pharmaceutical Market
|
Jennings Policy Strategies | |||
Details Advocate for biopharmaceutical cost containment policies aimed at creating a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limi... |
Momenta Pharmaceuticals, Inc.
|
Jennings Policy Strategies | |||
Details Advocate for cost containment policies related to comparative effectiveness, health information technology, and for policies on broader health care reform initiatives (including but not limited to ... |
California Public Employees Retirement System
|
Jennings Policy Strategies | |||
Details Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, sci... |
Pharmaceutical Care Management Association
|
Jennings Policy Strategies | |||
Details Medicare coverage and reimbursement, including H.R. 1894, H.R. 3590 - Patient Protection and Affordable Care Act, and related legislation (provisions related to Medicare coverage and reimbursement ... |
Amgen, Inc.
|
Dow Lohnes Government Strategies LLC | |||
Details Potential pathway to restocking the defense national stockpile of tungsten concentrate; potential offtake agreement with Defense Logistics Agency for resupply of tungsten stockpile; potential US fi... |
Almonty Industries, Inc.
|
PARK STRATEGIES, LLC | |||
Details Monitored implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. H.R. 1281: Newborn Screening Saves Lives Reauthorization Act of 2014. Legislative efforts to h... |
Genzyme Corporation
|
W Strategies, LLC | |||
Details Issues related to the biogas to electricity pathway under the Renewable Fuel Standard (Interior & Environment Appropriations, H.R. 5376 Inflation Reduction Act, IRS section 30c), as well as impleme... |
Electrify America, LLC
|
Waxman Strategies | |||
Details FDA's accelerated approval pathway; insulin price cap; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; Pandemic and All-Hazards Preparedness Reauthorization Act ... |
Lilly USA, LLC
|
Crossroads Strategies, LLC | |||
Details Promoting awareness of the biopharmaceutical and medical technology sectors. Opposing the imposition of price controls in the Medicare Part D program. Generally supporting intellectual property rig... |
HealthCare Institute of New Jersey
|
in-house lobbying | |||
Details Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss support for the 340B Drug Pricing Program with Congressional staff and oppose chan... |
Greater New York Hospital Association
|
in-house lobbying | |||
Details Supported efforts to swiftly and effectively implement the dairy provisions of the 2018 Farm Bill, including the Dairy Margin Coverage program and expanded access to the Livestock Gross Margin prog... |
NATIONAL MILK PRODUCERS FEDERATION
|
in-house lobbying | |||
Details H.R.132 - To amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to include algal blooms in the definition of a major disaster, and for other purposes. (Vern Buchanan, R-FL-16... |
NATIONAL ASSOCIATION OF MUTUAL INSURANCE COMPANIES
|
in-house lobbying |